Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Tadpole Model Links Drug Exposure to Autism-Like Effects

February 18, 2015 10:31 am | by Brown University | News | Comments

Research suggests that fetal exposure to chemicals or drugs can cause neurological problems. Babies whose mothers take the epilepsy drug valporic acid (VPA) during pregnancy, for example, appear to have an elevated risk of developing an autism spectrum disorder. Read more...


After Lobbying Push, Drugmaker Resubmits Women's Sex Pill

February 18, 2015 10:21 am | by Matthew Perrone, AP Health Writer - Associated Press | News | Comments

The makers of a twice-rejected pill designed to boost sexual desire in women are hoping a yearlong lobbying push by politicians, women's groups and consumer advocates will move their much-debated drug onto the market. The ongoing saga of Sprout Pharmaceutical's female libido drug illustrates the complicated politics and unresolved science surrounding women's sexuality. Read more...

Taking Technology from the Lab to the Patient

February 18, 2015 10:17 am | by MIT | News | Comments

After finishing his PhD in molecular genetics in the late 1990s, Daniel Anderson found himself conflicted about what to do next: He enjoyed science, but wanted to find a way to have a direct impact on human health. Read more...


Senior Pharmaceutical Executives Establish Business, next20

February 18, 2015 10:03 am | News | Comments

Three highly-experienced pharmaceutical and healthcare industry executives have formed next20, a new "Thought Partnership" which provides strategic support to help healthcare and pharmaceutical companies of all sizes identify and fully-leverage revenue opportunities. Read more...


Oncolytics: Enrollment Completion for Phase 2 Randomized Colorectal Cancer Study

February 18, 2015 9:08 am | News | Comments

The trial is being sponsored and conducted by the NCIC Clinical Trials Group. Read more...                            


New Drug Target for Multiple Sclerosis Discovered

February 18, 2015 8:59 am | by Centre for Addiction and Mental Health | News | Comments

Scientists have discovered a promising new approach to treat multiple sclerosis. Read more...                            


Lung Cancer Breath Test in Clinical Trial

February 18, 2015 8:55 am | by University of Leicester | News | Comments

A clinical trial exploring a potentially ground-breaking ‘breath test’ to detect lung cancer is set to get underway. Read more...                      


Computer Algorithm Picks Out the Drugs that Work

February 18, 2015 8:49 am | by Oxford University | News | Comments

More than 90 percent of central nervous system drugs fail when they're tried in large human trials. Read more...                         


Actavis Plans Corporate Name Change to Allergan

February 18, 2015 8:44 am | News | Comments

Actavis will change the company name after the completed acquisition of Allergan. Read more...                            


In Pakistan, Vaccinating Children Has Become a Deadly Battle

February 18, 2015 8:38 am | by Rebecca Santana, Associated Press | News | Comments

While vaccine distrust has sparked debates amid a measles outbreak in the United States, Pakistan is in a deadly battle to wipe out polio. Read more...                  


Link Between Genetic Switch, Autoimmune Diseases

February 17, 2015 12:53 pm | by NIH | News | Comments

Investigators with the National Institutes of Health have discovered the genomic switches of a blood cell key to regulating the human immune system. The findings, published in Nature, open the door to new research and development in drugs and personalized medicine to help those with autoimmune disorders such as inflammatory bowel disease or rheumatoid arthritis. Read more...


Ovarian Cancer Target Could Mean Earlier Detection, Treatments

February 17, 2015 12:32 pm | by The Wistar Institute | News | Comments

Researchers at The Wistar Institute have made an exciting discovery in a form of ovarian cancer, often considered one of the most difficult-to-treat forms of cancer. In a new study published in the journal Nature Medicine, this potential target could lead to both biomarkers for earlier detection of the disease as well as serve as a basis for new targeted therapies.


Improving Chemo Use in Prostate Cancer

February 17, 2015 12:21 pm | by Thomas Jefferson University | News | Comments

Prostate cancer is the second leading cause of cancer for men in the United States. Only one class of chemotherapy called taxanes is effective against the disease. A study published online in Clinical Cancer Research, researchers have found that a newer member of the taxane family...

Schools Start Treating E-Cigs as Drug Paraphernalia

February 17, 2015 11:58 am | by Michael Felberbaum, AP Tobacco Writer - Associated Press | News | Comments

Some schools are getting tougher on e-cigarettes, even punishing possession of the devices more harshly than regular cigarettes. Read more...

Amid Measles Outbreak, Few Rules on Teacher Vaccinations

February 17, 2015 11:53 am | by Christine Armario, Associated Press | News | Comments

While much of the attention in the ongoing measles outbreak has focused on student vaccination requirements and exemptions, less attention has been paid to another group in the nation's classrooms: Teachers and staff members, who, by and large, are not required to be vaccinated. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.